Connect your AI

Janux Therapeutics JANX Net margin

Net margin at other companies

Johnson & JohnsonJNJ

21.8%-2.6pp

AmgenAMGN

21%+3.6pp

Regeneron PharmaceuticalsREGN

29.6%-2.3pp

XencorXNCR

-177.1%+16.5pp

AbbVieABBV

5.8%-1.5pp

Nektar TherapeuticsNKTR

-284.2%+937pp

Other financials

Income statement

Revenue$3.7M—

Operating income-$34.2M+2.0%

Net income-$24.4M-3.6%

EPS (diluted)-$0.39-2.6%

Balance sheet

Cash & equivalents$51.8M-29.7%

Total debt$21.6M-4.6%

Total equity$941.5M-7.0%

Total assets$1.0B-2.1%

Cash flow

Operating cash flow-$12.3M+27.5%

CapEx$273.0K-26.4%

Free cash flow-$12.6M+27.5%

Valuation

Market cap$892.81M-36.1%

Enterprise value$862.55M-35.9%

P/S65×-84.6×

Profitability

Operating margin-1,143.1%-65.1pp

FCF margin-571.6%+98.3pp

Returns & leverage

Return on equity-11.7%+4.1pp

Debt / equity0×0.0×

Current ratio17×-41.5×

Where this comes from

Calculated from Janux Therapeutics’s reported figures.

net income/total revenue=-833.6%

Based on trailing twelve months.

The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Janux Therapeutics's net margin?: Janux Therapeutics (JANX) reported net margin of -833.6% in Q1 2026.
How has Janux Therapeutics's net margin changed year-over-year?: Janux Therapeutics's net margin decreased by 0.1% year-over-year, from -832.7% to -833.6%.
What is the long-term trend for Janux Therapeutics's net margin?: Over 4 years (2021 to 2025), Janux Therapeutics's net margin has grown at a 6.0% compound annual growth rate (CAGR), from -898.3% to -1,136.3%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.